DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Assertio Therapeutics Q4 Adj. EPS $(0.14), Sales $59.2M Beat $50.3M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly losses of $(0.14) per share. The company reported quarterly sales of $59.2 million which beat the analyst consensus estimate of $50.3 million by 17.69 percent.

Benzinga · 03/09/2020 20:03

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly losses of $(0.14) per share. The company reported quarterly sales of $59.2 million which beat the analyst consensus estimate of $50.3 million by 17.69 percent. This is a 38.97 percent increase over sales of $42.599 million the same period last year.